Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Soju Chang, M.D., M.P.H., Dawn M. Sievert, M.S., Jeffrey C. Hageman, M.H.S., Matthew L. Boulton, M.D., Fred C. Tenover, Ph.D., M.P.H., Frances Pouch Downes, Dr.P.H., Sandip Shah, M.S., James T. Rudrik, Ph.D., Guy R. Pupp, D.P.M., William J. Brown, Ph.D., Denise Cardo, M.D., Scott K. Fridkin, M.D., for the Vancomycin-Resistant Staphylococcus aureus Investigative Team
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
Until recently, vancomycin was the only uniformly effectivetreatment for staphylococcal infections. In 1997, the firstclinical isolate of Staphylococcus aureus with reduced susceptibilityto vancomycin was reported,1 and as of June 2002, eight confirmedinfections with such strains had been reported in patients inthe United States.2,3,4,5,6 The minimal inhibitory concentrations(MICs) of vancomycin reported for these isolates are in theintermediate range (8 to 16 µg per milliliter) accordingto interpretive criteria defined by the National Committee forClinical Laboratory Standards.7
In June 2002, a clinical isolate of vancomycin-resistant S.aureus (VRSA) (MIC, >32 µg per milliliter) was . . . [Full Text of this Article]
Case Report
Methods
Results
Epidemiologic Studies
Laboratory Studies
Discussion
Source Information
From the Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office (S.C.), and the Division of Healthcare Quality Promotion, National Center for Infectious Diseases (J.C.H., F.C.T., D.C., S.K.F.), Centers for Disease Control and Prevention, Atlanta; the Bureau of Epidemiology (D.M.S., M.L.B.) and the Bureau of Laboratories (F.P.D., S.S., J.T.R.), Michigan Department of Community Health, Lansing; Lakeview Podiatry Associates, Dearborn, Mich. (G.R.P.); and the Department of Pathology, Wayne State University School of Medicine and Detroit Medical Center University Laboratories, Detroit (W.J.B.).
Address reprint requests to Dr. Fridkin at the Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop A-35, Atlanta, GA 30333, or at sfridkin@cdc.gov.
This article has been cited by other articles:
Jones, R. C., Deck, J., Edmondson, R. D., Hart, M. E.
(2008). Relative Quantitative Comparisons of the Extracellular Protein Profiles of Staphylococcus aureus UAMS-1 and Its sarA, agr, and sarA agr Regulatory Mutants Using One-Dimensional Polyacrylamide Gel Electrophoresis and Nanocapillary Liquid Chromatography Coupled with Tandem Mass Spectrometry . J. Bacteriol.
190: 5265-5278
[Abstract][Full Text]
Kihara, R., Yanagihara, K., Morinaga, Y., Araki, N., Nakamura, S., Seki, M., Izumikawa, K., Kakeya, H., Yamamoto, Y., Tsukamoto, K., Kamihira, S., Kohno, S.
(2008). Potency of SMP-601, a Novel Carbapenem, in Hematogenous Murine Bronchopneumonia Caused by Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother.
52: 2163-2168
[Abstract][Full Text]
Malhotra-Kumar, S., Haccuria, K., Michiels, M., Ieven, M., Poyart, C., Hryniewicz, W., Goossens, H., on behalf of the MOSAR WP2 Study Team,
(2008). Current Trends in Rapid Diagnostics for Methicillin-Resistant Staphylococcus aureus and Glycopeptide-Resistant Enterococcus Species. J. Clin. Microbiol.
46: 1577-1587
[Full Text]
Noto, M. J., Fox, P. M., Archer, G. L.
(2008). Spontaneous Deletion of the Methicillin Resistance Determinant, mecA, Partially Compensates for the Fitness Cost Associated with High-Level Vancomycin Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother.
52: 1221-1229
[Abstract][Full Text]
Anderson, J. F., Parrish, T. D., Akhtar, M., Zurek, L., Hirt, H.
(2008). Antibiotic Resistance of Enterococci in American Bison (Bison bison) from a Nature Preserve Compared to That of Enterococci in Pastured Cattle. Appl. Environ. Microbiol.
74: 1726-1730
[Abstract][Full Text]
Arias, C. A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castaneda, E., Villegas, M. V., Murray, B. E., Quinn, J. P.
(2008). Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase. J. Clin. Microbiol.
46: 892-896
[Abstract][Full Text]
Maresso, A. W., Schneewind, O.
(2008). Sortase as a Target of Anti-Infective Therapy. Pharmacol. Rev.
60: 128-141
[Abstract][Full Text]
Zhu, W., Clark, N. C., McDougal, L. K., Hageman, J., McDonald, L. C., Patel, J. B.
(2008). Vancomycin-Resistant Staphylococcus aureus Isolates Associated with Inc18-Like vanA Plasmids in Michigan. Antimicrob. Agents Chemother.
52: 452-457
[Abstract][Full Text]
Saha, B., Singh, A. K., Ghosh, A., Bal, M.
(2008). Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol
57: 72-79
[Abstract][Full Text]
Rupp, M. E., Holley, H. P. Jr., Lutz, J., Dicpinigaitis, P. V., Woods, C. W., Levine, D. P., Veney, N., Fowler, V. G. Jr.
(2007). Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia. Antimicrob. Agents Chemother.
51: 4249-4254
[Abstract][Full Text]
Deplano, A., Denis, O., Nonhoff, C., Rost, F., Byl, B., Jacobs, F., Vankerckhoven, V., Goossens, H., Struelens, M. J.
(2007). Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control. J Antimicrob Chemother
60: 849-854
[Abstract][Full Text]
Citron, D. M., Goldstein, E. J. C., Merriam, C. V., Lipsky, B. A., Abramson, M. A.
(2007). Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents. J. Clin. Microbiol.
45: 2819-2828
[Abstract][Full Text]
Goff, D. A., Dowzicky, M. J.
(2007). Prevalence and regional variation in meticillin-resistant Staphylococcus aureus (MRSA) in the USA and comparative in vitro activity of tigecycline, a glycylcycline antimicrobial. J Med Microbiol
56: 1189-1193
[Abstract][Full Text]
Maresso, A. W., Wu, R., Kern, J. W., Zhang, R., Janik, D., Missiakas, D. M., Duban, M.-E., Joachimiak, A., Schneewind, O.
(2007). Activation of Inhibitors by Sortase Triggers Irreversible Modification of the Active Site. J. Biol. Chem.
282: 23129-23139
[Abstract][Full Text]
Miro, J. M., Garcia-de-la-Maria, C., Armero, Y., de-Lazzari, E., Soy, D., Moreno, A., del Rio, A., Almela, M., Mestres, C. A., Gatell, J. M., Jimenez-de-Anta, M.-T., Marco, F., and the Hospital Clinic Experimental Endocarditis,
(2007). Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother.
51: 2373-2377
[Abstract][Full Text]
Mortin, L. I., Li, T., Van Praagh, A. D. G., Zhang, S., Zhang, X.-X., Alder, J. D.
(2007). Rapid Bactericidal Activity of Daptomycin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Peritonitis in Mice as Measured with Bioluminescent Bacteria. Antimicrob. Agents Chemother.
51: 1787-1794
[Abstract][Full Text]
Fosheim, G. E., Carey, R. B., Limbago, B. M.
(2007). Evaluation of the AdvanDx VRE EVIGENE Assay for Detection of vanA in Vancomycin-Resistant Staphylococcus aureus. J. Clin. Microbiol.
45: 1611-1613
[Abstract][Full Text]
Maor, Y., Rahav, G., Belausov, N., Ben-David, D., Smollan, G., Keller, N.
(2007). Prevalence and Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Tertiary Care Center. J. Clin. Microbiol.
45: 1511-1514
[Abstract][Full Text]
Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R., Hachem, R.
(2007). Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm. Antimicrob. Agents Chemother.
51: 1656-1660
[Abstract][Full Text]
Valsesia, G., Medaglia, G., Held, M., Minas, W., Panke, S.
(2007). Circumventing the Effect of Product Toxicity: Development of a Novel Two-Stage Production Process for the Lantibiotic Gallidermin. Appl. Environ. Microbiol.
73: 1635-1645
[Abstract][Full Text]
Wootton, M., MacGowan, A. P., Walsh, T. R., Howe, R. A.
(2007). A Multicenter Study Evaluating the Current Strategies for Isolating Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides. J. Clin. Microbiol.
45: 329-332
[Abstract][Full Text]
French, G. L.
(2006). Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother
58: 1107-1117
[Abstract][Full Text]
Stranger-Jones, Y. K., Bae, T., Schneewind, O.
(2006). Vaccine assembly from surface proteins of Staphylococcus aureus. Proc. Natl. Acad. Sci. USA
103: 16942-16947
[Abstract][Full Text]
Cremniter, J., Mainardi, J.-L., Josseaume, N., Quincampoix, J.-C., Dubost, L., Hugonnet, J.-E., Marie, A., Gutmann, L., Rice, L. B., Arthur, M.
(2006). Novel Mechanism of Resistance to Glycopeptide Antibiotics in Enterococcus faecium. J. Biol. Chem.
281: 32254-32262
[Abstract][Full Text]
Revazishvili, T., Bakanidze, L., Gomelauri, T., Zhgenti, E., Chanturia, G., Kekelidze, M., Rajanna, C., Kreger, A., Sulakvelidze, A.
(2006). Genetic Background and Antibiotic Resistance of Staphylococcus aureus Strains Isolated in the Republic of Georgia.. J. Clin. Microbiol.
44: 3477-3483
[Abstract][Full Text]
Fox, P. M., Lampen, R. J., Stumpf, K. S., Archer, G. L., Climo, M. W.
(2006). Successful Therapy of Experimental Endocarditis Caused by Vancomycin-Resistant Staphylococcus aureus with a Combination of Vancomycin and {beta}-Lactam Antibiotics.. Antimicrob. Agents Chemother.
50: 2951-2956
[Abstract][Full Text]
Diederen, B. M. W., van Duijn, I., Willemse, P., Kluytmans, J. A. J. W.
(2006). In Vitro Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus, Including Heterogeneously Glycopeptide-Resistant Strains.. Antimicrob. Agents Chemother.
50: 3189-3191
[Abstract][Full Text]
Denis, O., Deplano, A., Nonhoff, C., Hallin, M., De Ryck, R., Vanhoof, R., De Mendonca, R., Struelens, M. J.
(2006). In Vitro Activities of Ceftobiprole, Tigecycline, Daptomycin, and 19 Other Antimicrobials against Methicillin-Resistant Staphylococcus aureus Strains from a National Survey of Belgian Hospitals.. Antimicrob. Agents Chemother.
50: 2680-2685
[Abstract][Full Text]
McCallum, N., Karauzum, H., Getzmann, R., Bischoff, M., Majcherczyk, P., Berger-Bachi, B., Landmann, R.
(2006). In Vivo Survival of Teicoplanin-Resistant Staphylococcus aureus and Fitness Cost of Teicoplanin Resistance.. Antimicrob. Agents Chemother.
50: 2352-2360
[Abstract][Full Text]
Pankuch, G. A., Lin, G., Hoellman, D. B., Good, C. E., Jacobs, M. R., Appelbaum, P. C.
(2006). Activity of Retapamulin against Streptococcus pyogenes and Staphylococcus aureus Evaluated by Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methodologies.. Antimicrob. Agents Chemother.
50: 1727-1730
[Abstract][Full Text]
Hasman, H., Aarestrup, F. M., Dalsgaard, A., Guardabassi, L.
(2006). Heterologous expression of glycopeptide resistance vanHAX gene clusters from soil bacteria in Enterococcus faecalis. J Antimicrob Chemother
57: 648-653
[Abstract][Full Text]
Gemmell, C. G., Edwards, D. I., Fraise, A. P., Gould, F. K., Ridgway, G. L., Warren, R. E., on behalf of the Joint Working Party of the Britis,
(2006). Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother
57: 589-608
[Abstract][Full Text]
Yang, Y., Severin, A., Chopra, R., Krishnamurthy, G., Singh, G., Hu, W., Keeney, D., Svenson, K., Petersen, P. J., Labthavikul, P., Shlaes, D. M., Rasmussen, B. A., Failli, A. A., Shumsky, J. S., Kutterer, K. M. K., Gilbert, A., Mansour, T. S.
(2006). 3,5-Dioxopyrazolidines, Novel Inhibitors of UDP-N- Acetylenolpyruvylglucosamine Reductase (MurB) with Activity against Gram-Positive Bacteria. Antimicrob. Agents Chemother.
50: 556-564
[Abstract][Full Text]
Sorum, M., Johnsen, P. J., Aasnes, B., Rosvoll, T., Kruse, H., Sundsfjord, A., Simonsen, G. S.
(2006). Prevalence, Persistence, and Molecular Characterization of Glycopeptide-Resistant Enterococci in Norwegian Poultry and Poultry Farmers 3 to 8 Years after the Ban on Avoparcin. Appl. Environ. Microbiol.
72: 516-521
[Abstract][Full Text]
Short, B. R. D., Vargas, M. A., Thomas, J. C., O'Hanlon, S., Enright, M. C.
(2006). In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother
57: 104-109
[Abstract][Full Text]
Yanagihara, K., Tashiro, M., Fukuda, Y., Ohno, H., Higashiyama, Y., Miyazaki, Y., Hirakata, Y., Tomono, K., Mizuta, Y., Tsukamoto, K., Kohno, S.
(2006). Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J Antimicrob Chemother
57: 122-126
[Abstract][Full Text]
Eisner, A., Feierl, G., Gorkiewicz, G., Dieber, F., Kessler, H. H., Marth, E., Kofer, J.
(2005). High Prevalence of VanA-Type Vancomycin-Resistant Enterococci in Austrian Poultry. Appl. Environ. Microbiol.
71: 6407-6409
[Abstract][Full Text]
Vaudaux, P., Gjinovci, A., Bento, M., Li, D., Schrenzel, J., Lew, D. P.
(2005). Intensive Therapy with Ceftobiprole Medocaril of Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
49: 3789-3793
[Abstract][Full Text]
Sinsimer, D., Leekha, S., Park, S., Marras, S. A. E., Koreen, L., Willey, B., Naidich, S., Musser, K. A., Kreiswirth, B. N.
(2005). Use of a Multiplex Molecular Beacon Platform for Rapid Detection of Methicillin and Vancomycin Resistance in Staphylococcus aureus. J. Clin. Microbiol.
43: 4585-4591
[Abstract][Full Text]
Raja, N S, Karunakaran, R, Ngeow, Y F, Awang, R
(2005). Community-acquired vancomycin-resistant Enterococcus faecium: a case report from Malaysia. J Med Microbiol
54: 901-903
[Abstract][Full Text]
Domanski, P. J., Patel, P. R., Bayer, A. S., Zhang, L., Hall, A. E., Syribeys, P. J., Gorovits, E. L., Bryant, D., Vernachio, J. H., Hutchins, J. T., Patti, J. M.
(2005). Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus. Infect. Immun.
73: 5229-5232
[Abstract][Full Text]
Fraimow, H., Knob, C., Herrero, I. A., Patel, R.
(2005). Putative VanRS-Like Two-Component Regulatory System Associated with the Inducible Glycopeptide Resistance Cluster of Paenibacillus popilliae. Antimicrob. Agents Chemother.
49: 2625-2633
[Abstract][Full Text]
Fujikawa, K., Chiba, M., Tanaka, M., Sato, K.
(2005). In Vitro Antibacterial Activity of DX-619, a Novel Des-Fluoro(6) Quinolone. Antimicrob. Agents Chemother.
49: 3040-3045
[Abstract][Full Text]
O'May, G. A., Reynolds, N., Smith, A. R., Kennedy, A., Macfarlane, G. T.
(2005). Effect of pH and Antibiotics on Microbial Overgrowth in the Stomachs and Duodena of Patients Undergoing Percutaneous Endoscopic Gastrostomy Feeding. J. Clin. Microbiol.
43: 3059-3065
[Abstract][Full Text]
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G. Jr, Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., Tong, D. C., Steckelberg, J. M., Baltimore, R. S., Shulman, S. T., Burns, J. C., Falace, D. A., Newburger, J. W., Pallasch, T. J., Takahashi, M., Taubert, K. A.
(2005). Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation
111: e394-e434
[Abstract][Full Text]
Schriever, C. A., Fernandez, C., Rodvold, K. A., Danziger, L. H.
(2005). Daptomycin: A novel cyclic lipopeptide antimicrobial. Am J Health Syst Pharm
62: 1145-1158
[Abstract][Full Text]
Yin, L.-Y., Lazzarini, L., Li, F., Stevens, C. M., Calhoun, J. H.
(2005). Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother
55: 995-1002
[Abstract][Full Text]
Hong, H.-J., Hutchings, M. I., Hill, L. M., Buttner, M. J.
(2005). The Role of the Novel Fem Protein VanK in Vancomycin Resistance in Streptomyces coelicolor. J. Biol. Chem.
280: 13055-13061
[Abstract][Full Text]
Ingavale, S., van Wamel, W., Luong, T. T., Lee, C. Y., Cheung, A. L.
(2005). Rat/MgrA, a Regulator of Autolysis, Is a Regulator of Virulence Genes in Staphylococcus aureus. Infect. Immun.
73: 1423-1431
[Abstract][Full Text]
Gonzalez-Zorn, B., Senna, J. P. M., Fiette, L., Shorte, S., Testard, A., Chignard, M., Courvalin, P., Grillot-Courvalin, C.
(2005). Bacterial and Host Factors Implicated in Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Mice. Infect. Immun.
73: 1847-1851
[Abstract][Full Text]
Shutt, C. K., Pounder, J. I., Page, S. R., Schaecher, B. J., Woods, G. L.
(2005). Clinical Evaluation of the DiversiLab Microbial Typing System Using Repetitive-Sequence-Based PCR for Characterization of Staphylococcus aureus Strains. J. Clin. Microbiol.
43: 1187-1192
[Abstract][Full Text]
(2005). Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am. J. Respir. Crit. Care Med.
171: 388-416
[Full Text]
Shibata, H., Kondo, K., Katsuyama, R., Kawazoe, K., Sato, Y., Murakami, K., Takaishi, Y., Arakaki, N., Higuti, T.
(2005). Alkyl Gallates, Intensifiers of {beta}-Lactam Susceptibility in Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
49: 549-555
[Abstract][Full Text]
Clark, N. C., Weigel, L. M., Patel, J. B., Tenover, F. C.
(2005). Comparison of Tn1546-Like Elements in Vancomycin-Resistant Staphylococcus aureus Isolates from Michigan and Pennsylvania. Antimicrob. Agents Chemother.
49: 470-472
[Abstract][Full Text]
Benton, B. M., Zhang, J. P., Bond, S., Pope, C., Christian, T., Lee, L., Winterberg, K. M., Schmid, M. B., Buysse, J. M.
(2004). Large-Scale Identification of Genes Required for Full Virulence of Staphylococcus aureus. J. Bacteriol.
186: 8478-8489
[Abstract][Full Text]
Severin, A., Wu, S. W., Tabei, K., Tomasz, A.
(2004). Penicillin-Binding Protein 2 Is Essential for Expression of High-Level Vancomycin Resistance and Cell Wall Synthesis in Vancomycin- Resistant Staphylococcus aureus Carrying the Enterococcal vanA Gene Complex. Antimicrob. Agents Chemother.
48: 4566-4573
[Abstract][Full Text]
Patel, M. V., De Souza, N. J., Gupte, S. V., Jafri, M. A., Bhagwat, S. S., Chugh, Y., Khorakiwala, H. F., Jacobs, M. R., Appelbaum, P. C.
(2004). Antistaphylococcal Activity of WCK 771, a Tricyclic Fluoroquinolone, in Animal Infection Models. Antimicrob. Agents Chemother.
48: 4754-4761
[Abstract][Full Text]
Bozdogan, B., Ednie, L., Credito, K., Kosowska, K., Appelbaum, P. C.
(2004). Derivatives of a Vancomycin-Resistant Staphylococcus aureus Strain Isolated at Hershey Medical Center. Antimicrob. Agents Chemother.
48: 4762-4765
[Abstract][Full Text]
Nishi, H., Komatsuzawa, H., Fujiwara, T., McCallum, N., Sugai, M.
(2004). Reduced Content of Lysyl-Phosphatidylglycerol in the Cytoplasmic Membrane Affects Susceptibility to Moenomycin, as Well as Vancomycin, Gentamicin, and Antimicrobial Peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother.
48: 4800-4807
[Abstract][Full Text]
Vouillamoz, J., Entenza, J. M., Hohl, P., Moreillon, P.
(2004). LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
48: 4322-4327
[Abstract][Full Text]
Horstkotte, M. A., Knobloch, J. K.-M., Rohde, H., Dobinsky, S., Mack, D.
(2004). Evaluation of the BD PHOENIX Automated Microbiology System for Detection of Methicillin Resistance in Coagulase-Negative Staphylococci. J. Clin. Microbiol.
42: 5041-5046
[Abstract][Full Text]
Roos, K. L.
(2004). Emerging Antimicrobial-Resistant Infections. Arch Neurol
61: 1512-1514
[Full Text]
Epstein, B. J, Gums, J. G, Drlica, K.
(2004). The Changing Face of Antibiotic Prescribing: The Mutant Selection Window. The Annals of Pharmacotherapy
38: 1675-1682
[Abstract][Full Text]
Jacobs, M. R., Bajaksouzian, S., Windau, A., Appelbaum, P. C., Patel, M. V., Gupte, S. V., Bhagwat, S. S., De Souza, N. J., Khorakiwala, H. F.
(2004). In Vitro Activity of the New Quinolone WCK 771 against Staphylococci. Antimicrob. Agents Chemother.
48: 3338-3342
[Abstract][Full Text]
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., Ljungh, A.
(2004). Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother
54: 648-653
[Abstract][Full Text]
Bae, T., Banger, A. K., Wallace, A., Glass, E. M., Aslund, F., Schneewind, O., Missiakas, D. M.
(2004). Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc. Natl. Acad. Sci. USA
101: 12312-12317
[Abstract][Full Text]
Maki, H., McCallum, N., Bischoff, M., Wada, A., Berger-Bachi, B.
(2004). tcaA Inactivation Increases Glycopeptide Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother.
48: 1953-1959
[Abstract][Full Text]
David, V., Bozdogan, B., Mainardi, J.-L., Legrand, R., Gutmann, L., Leclercq, R.
(2004). Mechanism of Intrinsic Resistance to Vancomycin in Clostridium innocuum NCIB 10674. J. Bacteriol.
186: 3415-3422
[Abstract][Full Text]
King, A., Phillips, I., Kaniga, K.
(2004). Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria. J Antimicrob Chemother
53: 797-803
[Abstract][Full Text]
Lu, W., Oberthur, M., Leimkuhler, C., Tao, J., Kahne, D., Walsh, C. T.
(2004). Characterization of a regiospecific epivancosaminyl transferase GtfA and enzymatic reconstitution of the antibiotic chloroeremomycin. Proc. Natl. Acad. Sci. USA
101: 4390-4395
[Abstract][Full Text]
Verdier, I., Reverdy, M.-E., Etienne, J., Lina, G., Bes, M., Vandenesch, F.
(2004). Staphylococcus aureus Isolates with Reduced Susceptibility to Glycopeptides Belong to Accessory Gene Regulator Group I or II. Antimicrob. Agents Chemother.
48: 1024-1027
[Abstract][Full Text]
Sande, M. A., Ronald, A. R.
(2004). Update in Infectious Diseases. ANN INTERN MED
140: 290-295
[Full Text]
Dubrac, S., Msadek, T.
(2004). Identification of Genes Controlled by the Essential YycG/YycF Two-Component System of Staphylococcus aureus. J. Bacteriol.
186: 1175-1181
[Abstract][Full Text]
Koreen, L., Ramaswamy, S. V., Graviss, E. A., Naidich, S., Musser, J. M., Kreiswirth, B. N.
(2004). spa Typing Method for Discriminating among Staphylococcus aureus Isolates: Implications for Use of a Single Marker To Detect Genetic Micro- and Macrovariation. J. Clin. Microbiol.
42: 792-799
[Abstract][Full Text]
Miller, M. B., Allen, S. L., Mangum, M. E., Doutova, A., Gilligan, P. H.
(2004). Prevalence of Vancomycin-Resistant Enterococcus in Prenatal Screening Cultures. J. Clin. Microbiol.
42: 855-857
[Abstract][Full Text]
Severin, A., Tabei, K., Tenover, F., Chung, M., Clarke, N., Tomasz, A.
(2004). High Level Oxacillin and Vancomycin Resistance and Altered Cell Wall Composition in Staphylococcus aureus Carrying the Staphylococcal mecA and the Enterococcal vanA Gene Complex. J. Biol. Chem.
279: 3398-3407
[Abstract][Full Text]
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., Patel, J. B., Bozdogan, B.
(2004). Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania. Antimicrob. Agents Chemother.
48: 275-280
[Abstract][Full Text]
Comenge, Y., Quintiliani, R. Jr., Li, L., Dubost, L., Brouard, J.-P., Hugonnet, J.-E., Arthur, M.
(2003). The CroRS Two-Component Regulatory System Is Required for Intrinsic {beta}-Lactam Resistance in Enterococcus faecalis. J. Bacteriol.
185: 7184-7192
[Abstract][Full Text]
Robinson, D. A., Enright, M. C.
(2003). Evolutionary Models of the Emergence of Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
47: 3926-3934
[Abstract][Full Text]
Flannagan, S. E., Chow, J. W., Donabedian, S. M., Brown, W. J., Perri, M. B., Zervos, M. J., Ozawa, Y., Clewell, D. B.
(2003). Plasmid Content of a Vancomycin-Resistant Enterococcus faecalis Isolate from a Patient Also Colonized by Staphylococcus aureus with a VanA Phenotype. Antimicrob. Agents Chemother.
47: 3954-3959
[Abstract][Full Text]
Perry, J. D., Rennison, C., Butterworth, L. A., Hopley, A. L. J., Gould, F. K.
(2003). Evaluation of S. aureus ID, a New Chromogenic Agar Medium for Detection of Staphylococcus aureus. J. Clin. Microbiol.
41: 5695-5698
[Abstract][Full Text]
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., Tenover, F. C.
(2003). Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus. Science
302: 1569-1571
[Abstract][Full Text]
von Eiff, C., Kokai-Kun, J. F., Becker, K., Peters, G.
(2003). In Vitro Activity of Recombinant Lysostaphin against Staphylococcus aureus Isolates from Anterior Nares and Blood. Antimicrob. Agents Chemother.
47: 3613-3615
[Abstract][Full Text]
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., Tenover, F. C.
(2003). Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus aureus Isolates from the United States: Establishing a National Database. J. Clin. Microbiol.
41: 5113-5120
[Abstract][Full Text]
Gibson, R. L., Burns, J. L., Ramsey, B. W.
(2003). Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
168: 918-951
[Abstract][Full Text]
Liu, C., Chambers, H. F.
(2003). Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods. Antimicrob. Agents Chemother.
47: 3040-3045
[Full Text]
Previous
